Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to ES9902850ApriorityCriticalpatent/ES2165788B1/es
Publication of ES2165788A1publicationCriticalpatent/ES2165788A1/es
Application grantedgrantedCritical
Publication of ES2165788B1publicationCriticalpatent/ES2165788B1/es
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Coloring Foods And Improving Nutritive Qualities
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La administración de levadura de cerveza a pacientes con el síndrome X frágil mejora la sintomatología clínica de los pacientes (hipercinesia, trastornos del sueño, retraso cognitivo y del aprendizaje, trastornos de conducta y bulimia).
ES9902850A1999-12-211999-12-21Empleo de la levadura de cerveza en la elaboracion de un medicamento para el tratamiento del sindrome x fragil.
Expired - Fee RelatedES2165788B1
(es)
Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.